Quality management of medical aid and validity of risk at use of cellular technologies in system of obligatory medical insurance

A A Starchenko , D A Zinland , E N Tret'yakova , OB Tarasova , M Yu Furkalyuk , S A Komarets , I N Kurilo , E Yu Goncharova , M D Guzhenko , А А Starchenko , DA Zinland , E N Tretjakova , O V Tarasova , M J Furkaljuk , S A Komarets , I N Kurilo , E Ju Goncharova , M D Guzhenko

Genes & Cells ›› 2010, Vol. 5 ›› Issue (3) : 49 -50.

PDF
Genes & Cells ›› 2010, Vol. 5 ›› Issue (3) : 49 -50. DOI: 10.23868/gc121760
Articles
other

Quality management of medical aid and validity of risk at use of cellular technologies in system of obligatory medical insurance

Author information +
History +
PDF

Cite this article

Download citation ▾
A A Starchenko, D A Zinland, E N Tret'yakova, OB Tarasova, M Yu Furkalyuk, S A Komarets, I N Kurilo, E Yu Goncharova, M D Guzhenko, А А Starchenko, DA Zinland, E N Tretjakova, O V Tarasova, M J Furkaljuk, S A Komarets, I N Kurilo, E Ju Goncharova, M D Guzhenko. Quality management of medical aid and validity of risk at use of cellular technologies in system of obligatory medical insurance. Genes & Cells, 2010, 5(3): 49-50 DOI:10.23868/gc121760

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

61

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/